Trial Profile
Tolerability and Pharmacokinetics of Hydronidone Following Single and Multiple Oral Administrations in Healthy Chinese Volunteers: An Open-Label, Randomized, Single-Center Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Oct 2016
Price :
$35
*
At a glance
- Drugs Hydronidone (Primary)
- Indications Hepatic fibrosis; Liver cirrhosis
- Focus Adverse reactions; Pharmacokinetics
- 30 May 2016 New trial record